Somnath Mukhopadhyay to Receptor, Cannabinoid, CB2
This is a "connection" page, showing publications Somnath Mukhopadhyay has written about Receptor, Cannabinoid, CB2.
Connection Strength
0.937
-
McCollum L, Howlett AC, Mukhopadhyay S. Anandamide-mediated CB1/CB2 cannabinoid receptor--independent nitric oxide production in rabbit aortic endothelial cells. J Pharmacol Exp Ther. 2007 Jun; 321(3):930-7.
Score: 0.297
-
Mukhopadhyay S, Das S, Williams EA, Moore D, Jones JD, Zahm DS, Ndengele MM, Lechner AJ, Howlett AC. Lipopolysaccharide and cyclic AMP regulation of CB(2) cannabinoid receptor levels in rat brain and mouse RAW 264.7 macrophages. J Neuroimmunol. 2006 Dec; 181(1-2):82-92.
Score: 0.288
-
Khatri D, Laroche G, Grant ML, Jones VM, Vetreno RP, Crews FT, Mukhopadhyay S. Acute Ethanol Inhibition of Adult Hippocampal Neurogenesis Involves CB1 Cannabinoid Receptor Signaling. Alcohol Clin Exp Res. 2018 Apr; 42(4):718-726.
Score: 0.159
-
Balas L, Durand T, Saha S, Johnson I, Mukhopadhyay S. Total synthesis of photoactivatable or fluorescent anandamide probes: novel bioactive compounds with angiogenic activity. J Med Chem. 2009 Feb 26; 52(4):1005-17.
Score: 0.085
-
Mukhopadhyay S, Tulis DA. Endocannabinoid regulation of matrix metalloproteinases: implications in ischemic stroke. Cardiovasc Hematol Agents Med Chem. 2007 Oct; 5(4):311-8.
Score: 0.077
-
Hong J, Nandiwada V, Jones V, Lu M, Warner DS, Mukhopadhyay S, Sheng H. CB1 cannabinoid receptor agonist inhibits matrix metalloproteinase activity in spinal cord injury: A possible mechanism of improved recovery. Neurosci Lett. 2015 Jun 15; 597:19-24.
Score: 0.032